Phosphorylation of eIF2alpha is required for mRNA translation inhibition and survival during moderate hypoxia

Marianne Koritzinsky1, Kasper M A Rouschop, Twan van den Beucken

  • 1Department of Radiation Oncology (Maastro Lab), GROW Research Institute, Maastricht University, Maastricht, The Netherlands.

Abstract

Insights

Targeting eIF2alpha phosphorylation inhibits mRNA translation and enhances cancer cell sensitivity to hypoxia. This disruption offers a potential therapeutic strategy for hypoxia-directed cancer treatment.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cellular Physiology

Background:

  • Tumor microenvironments exhibit fluctuating oxygen levels, influencing biological pathways.
  • Hypoxia (low oxygen) inhibits mRNA translation via eIF2alpha, impacting tumor growth and gene expression.
  • The eIF2alpha phosphorylation pathway is a key regulator of cellular response to hypoxia and a potential cancer therapy target.

Purpose of the Study:

  • To investigate the role of eIF2alpha in regulating mRNA translation and hypoxia tolerance during moderate hypoxia.
  • To assess mRNA translation in various cancer cell lines due to frequent mutations in protein synthesis pathways.

Main Methods:

  • Assayed global mRNA translation efficiency using polysome analysis in human fibroblasts and cancer cell lines under varying oxygen levels.
  • Utilized genetic models, including eIF2alpha mutant MEFs and cells overexpressing GADD34, to assess eIF2alpha's role.
  • Investigated eIF4E regulation using shRNA targeting 4E-BP1 in HeLa cells.

Main Results:

  • All cell types showed inhibited mRNA translation under anoxia and hypoxia.
  • Moderate hypoxia-induced mRNA translation inhibition was dependent on eIF2alpha phosphorylation.
  • Disrupting eIF2alpha phosphorylation led to increased sensitivity to both hypoxia and anoxia.

Conclusions:

  • Disruption of eIF2alpha phosphorylation represents a promising therapeutic target for hypoxia-directed cancer treatment.
  • Modulating eIF2alpha phosphorylation could enhance the efficacy of cancer therapies targeting the tumor microenvironment.

Related Concept Videos

Stringent Response in E. coli01:23

Stringent Response in E. coli

Bacterial growth is closely tied to nutrient availability, with cells proliferating exponentially under favorable conditions and entering a stationary phase when resources become scarce. This transition is mediated by a regulatory mechanism known as the stringent response, which allows bacteria to adapt to nutrient deprivation by modulating gene expression and metabolic activity.During nutrient scarcity, intracellular amino acid levels decline. It results in the accumulation of uncharged tRNAs...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
Regulation of Expression at Multiple Steps01:23

Regulation of Expression at Multiple Steps

The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the addition of a...
Regulation of Expression Occurs at Multiple Steps02:24

Regulation of Expression Occurs at Multiple Steps

Gene expression can be regulated at almost every step from gene to protein. Transcription is the step that is most commonly regulated. This involves the binding of proteins to short regulatory sequences on the DNA. This association can either promote or inhibit the transcription of a gene associated with the respective sequence.
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...